Labcorp reported strong Q3 2026 financial results with revenue of $3.81 billion and net income of $262.8 million, surpassing prior guidance and raising full-year outlook. The company continues to implement its ERP system and expand collaborations to improve diagnostic testing access and drug abuse risk assessment.

• Labcorp Holdings Inc. reported Q3 2026 revenue of $3.81 billion and net income of $262.8 million, with basic EPS of $3.24 and diluted EPS of $3.22 [S2].
• The company raised its full-year guidance following the Q3 results, reflecting operational strength [N4].
• Labcorp is advancing the deployment of a new ERP system, which may affect supply chain and procurement processes during integration [S2].
• Collaborations with Charles River and the FDA aim to improve drug abuse risk assessment capabilities [N1].
• Partnerships with Waters expand access to FDA-approved HPV screening tests [N1].
• Recent earnings calls provided detailed insights into key metrics and operational highlights for Q3 2026 [N1, N2].

Labcorp's recent operational improvements, including ERP system upgrades and expanded collaborations for diagnostic testing, enhance its service capabilities and market reach. The company's ability to raise full-year guidance following strong quarterly results indicates operational resilience and potential for sustained revenue generation. Strategic partnerships with entities like the FDA and Charles River support innovation in drug abuse risk assessment and screening tests.

Risks include potential disruptions from the complex ERP system implementation, which could affect supply chain, procurement, and transaction processing. Dependence on third-party service providers and IT systems exposes Labcorp to cybersecurity and operational risks that could impact service delivery and financial performance. Regulatory and compliance challenges in the healthcare diagnostics industry also pose ongoing risks to operations and profitability.

Labcorp's moat is supported by its extensive network of diagnostic laboratories, established partnerships with regulatory bodies and industry players, and its broad service offerings in clinical testing. The company's scale and integration of advanced IT systems contribute to operational efficiencies and service reliability, which are critical in the healthcare diagnostics sector.

• Information Technology System Risks: Failures or cybersecurity incidents in Labcorp's IT systems or those of its vendors could disrupt operations, impair data processing, and affect financial results [S2].
• ERP System Implementation Risks: The ongoing deployment of a new ERP system is complex and may cause operational disruptions, data errors, or increased costs during integration [S2].
• Third-Party Service Provider Risks: Reliance on third parties for critical services exposes the company to risks from their operational, legal, or cybersecurity failures, which could materially impact Labcorp's business [S2].

• Labcorp Holdings Inc. operates in the diagnostics and healthcare services sector, providing clinical laboratory testing and related services.
• The company reported revenue of $3.81 billion for the quarter ended September 30, 2026, according to its 10-Q filing [S2].
• Net income for the same period was $262.8 million, with basic earnings per share of $3.24 and diluted EPS of $3.22 [S2].
• As of September 30, 2026, Labcorp held $261.8 million in cash and cash equivalents and had current assets of approximately $3.97 billion against current liabilities of about $2.82 billion, resulting in a current ratio of 1.41 and a cash ratio of 0.09 [S2].
• The company is implementing a new enterprise resource planning (ERP) system, which is complex and may affect operations during integration, including supply chain and procurement processes [S2].
• Labcorp collaborates with entities such as Charles River and the FDA to improve drug abuse risk assessment and has partnerships to expand access to FDA-approved HPV screening tests [N1, N4].
• Recent quarterly results for Q3 2026 showed earnings and revenues surpassing prior guidance, with the company raising its full-year outlook [N4, N8].
• Labcorp's operations depend heavily on the performance and security of its information technology systems, with risks related to system failures, cybersecurity incidents, and third-party service provider disruptions [S2].
• The company has contingency plans for IT disruptions but acknowledges that significant failures could adversely affect reputation, operations, financial condition, and profitability [S2].
• Labcorp's recent earnings calls and reports provide detailed insights into key metrics and operational highlights for Q3 2026 [N1, N2, N6].